CX Institutional’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.63M | Sell |
11,529
-1,031
| -8% | -$325K | 0.1% | 184 |
|
|
2026
Q1 | $4.13M | Sell |
12,560
-498
| -4% | -$179K | 0.13% | 177 |
|
|
2025
Q4 | $4.59M | Buy |
13,058
+1,015
| +8% | +$370K | 0.14% | 153 |
|
|
2025
Q3 | $4.45M | Buy |
12,043
+7,962
| +195% | +$3.08M | 0.14% | 153 |
|
|
2025
Q2 | $1.61M | Buy |
4,081
+66
| +2% | +$24.7K | 0.06% | 212 |
|
|
2025
Q1 | $1.5M | Sell |
4,015
-95
| -2% | -$36.2K | 0.06% | 225 |
|
|
2024
Q4 | $1.48M | Buy |
4,110
+632
| +18% | +$234K | 0.06% | 207 |
|
|
2024
Q3 | $1.26M | Buy |
3,478
+130
| +4% | +$44.9K | 0.06% | 253 |
|
|
2024
Q2 | $1.14M | Sell |
3,348
-21
| -0.6% | -$7.11K | 0.05% | 261 |
|
|
2024
Q1 | $1.21M | Sell |
3,369
-114
| -3% | -$38.4K | 0.06% | 254 |
|
|
2023
Q4 | $1.04M | Sell |
3,483
-211
| -6% | -$59.2K | 0.06% | 251 |
|
|
2023
Q3 | $1.01M | Sell |
3,694
-60
| -2% | -$17.2K | 0.06% | 251 |
|
|
2023
Q2 | $1.15M | Buy |
3,754
+113
| +3% | +$32.6K | 0.06% | 259 |
|
|
2023
Q1 | $1.05M | Buy |
3,641
+1,022
| +39% | +$271K | 0.06% | 270 |
|
|
2022
Q4 | $640K | Buy |
2,619
+898
| +52% | +$204K | 0.04% | 338 |
|
|
2022
Q3 | $349K | Buy |
1,721
+801
| +87% | +$168K | 0.02% | 375 |
|
|
2022
Q2 | $183K | Sell |
920
-462
| -33% | -$109K | 0.01% | 451 |
|
|
2022
Q1 | $369K | Buy |
1,382
+72
| +5% | +$18.6K | 0.03% | 291 |
|
|
2021
Q4 | $350K | Sell |
1,310
-53
| -4% | -$13.9K | 0.03% | 274 |
|
|
2021
Q3 | $359K | Buy |
1,363
+80
| +6% | +$21.4K | 0.03% | 294 |
|
|
2021
Q2 | $333K | Buy |
1,283
+205
| +19% | +$52.4K | 0.03% | 288 |
|
|
2021
Q1 | $263K | Sell |
1,078
-190
| -15% | -$45.6K | 0.02% | 274 |
|
|
2020
Q4 | $311K | Sell |
1,268
-1,352
| -52% | -$306K | 0.03% | 264 |
|
|
2020
Q3 | $546K | Buy |
2,620
+1,405
| +116% | +$273K | 0.06% | 199 |
|
|
2020
Q2 | $219K | Buy |
1,215
+219
| +22% | +$40.4K | 0.03% | 238 |
|
|
2020
Q1 | $166K | Sell |
996
-58
| -6% | -$11.3K | 0.03% | 240 |
|
|
2019
Q4 | $221K | Sell |
1,054
-114
| -10% | -$23.7K | 0.04% | 190 |
|
|
2019
Q3 | $253K | Buy |
1,168
+7
| +0.6% | +$1.5K | 0.04% | 202 |
|
|
2019
Q2 | $239K | Sell |
1,161
-150
| -11% | -$28.6K | 0.04% | 207 |
|
|
2019
Q1 | $259K | Buy |
1,311
+291
| +29% | +$52.4K | 0.05% | 192 |
|
|
2018
Q4 | $160K | Buy |
1,020
+5
| +0.5% | +$836 | 0.03% | 180 |
|
|
2018
Q3 | $180K | Sell |
1,015
-30
| -3% | -$5.12K | 0.06% | 122 |
|
|
2018
Q2 | $176K | Buy |
+1,045
| New | +$176K | 0.07% | 118 |
|
Other funds holding SYK
GT
ATO
FAM
AAIS
RG
BTW
DC
JIC
CX Institutional's SYK Position: Q2 2026 in Review
CX Institutional reduced its Stryker (SYK) stake by 8.2% in Q2 2026, selling an estimated $325K and leaving 11,529 shares worth $3.63M. The position accounts for 0.1% of the portfolio, ranked #184.
CX Institutional first reported a position in SYK in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.59M in Q4 2025. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.
- CX Institutional held 11,529 shares of Stryker worth $3.63M as of Q2 2026.
- CX Institutional sold 1,031 Stryker shares in Q2 2026, an estimated $325K.
- Stryker made up 0.1% of CX Institutional's portfolio in Q2 2026, its #184 holding.
- CX Institutional first reported a position in Stryker in Q2 2018 and has held it in 33 quarters since.
- CX Institutional's Stryker position peaked at $4.59M in Q4 2025.
- 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.